- Home
- ZIP vs PRTA Comparison
ZIP vs PRTA Comparison
Compare ZIP & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIP
- PRTA
- Stock Information
- Founded
- ZIP 2010
- PRTA 2012
- Country
- ZIP United States
- PRTA Ireland
- Employees
- ZIP N/A
- PRTA N/A
- Industry
- ZIP Diversified Commercial Services
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- ZIP Consumer Discretionary
- PRTA Health Care
- Exchange
- ZIP Nasdaq
- PRTA Nasdaq
- Market Cap
- ZIP 784.5M
- PRTA 765.2M
- IPO Year
- ZIP 2021
- PRTA N/A
- Fundamental
- Price
- ZIP $6.96
- PRTA $15.56
- Analyst Decision
- ZIP Hold
- PRTA Buy
- Analyst Count
- ZIP 6
- PRTA 8
- Target Price
- ZIP $9.80
- PRTA $46.00
- AVG Volume (30 Days)
- ZIP 464.2K
- PRTA 336.3K
- Earning Date
- ZIP 02-25-2025
- PRTA 02-20-2025
- Dividend Yield
- ZIP N/A
- PRTA N/A
- EPS Growth
- ZIP N/A
- PRTA N/A
- EPS
- ZIP 0.03
- PRTA N/A
- Revenue
- ZIP $498,903,000.00
- PRTA $135,157,000.00
- Revenue This Year
- ZIP N/A
- PRTA $56.89
- Revenue Next Year
- ZIP N/A
- PRTA N/A
- P/E Ratio
- ZIP $236.57
- PRTA N/A
- Revenue Growth
- ZIP N/A
- PRTA 47.92
- 52 Week Low
- ZIP $6.51
- PRTA $11.70
- 52 Week High
- ZIP $13.03
- PRTA $31.03
- Technical
- Relative Strength Index (RSI)
- ZIP 38.68
- PRTA 59.65
- Support Level
- ZIP $7.15
- PRTA $13.69
- Resistance Level
- ZIP $8.00
- PRTA $15.09
- Average True Range (ATR)
- ZIP 0.34
- PRTA 0.91
- MACD
- ZIP -0.05
- PRTA 0.13
- Stochastic Oscillator
- ZIP 19.56
- PRTA 68.56
About ZIP ZipRecruiter Inc.
ZipRecruiter Inc is an online employment marketplace. It was founded to make meaningful connections between job seekers and employers. It connects millions of job seekers with companies of all sizes. It is a two-sided marketplace for work that simplifies the job market for both job seekers and employers. Unlike traditional online job sites, ZipRecruiter works like a matchmaker curating job opportunities for job seekers, and candidates for employers.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).